Interní Med. 2001; 3(1): 22-25

Rizikové a protektivní faktory diabetické retinopatie

MUDr. Tomáš Sosna CSc
Oční ambulance kliniky diabetologie a experimentální terapie IKEM, Praha

Keywords: Diabetes mellitus, diabetická retinopatie, EW syndrom, rizikové faktory.

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sosna T. Rizikové a protektivní faktory diabetické retinopatie. Interní Med. 2001;3(1):22-25.

Vznik a rozvoj diabetické retinopatie (DR) je ovlivňován množstvím extraokulárních a okulárních rizikových i protektivních faktorů. Neokulární faktory hrají nesporně velkou úlohu v predispozici diabetika k DR. Okulární faktory jsou zřejmě zodpovědné za to jak, kdy a do jaké míry se tato predispozice rozvine. Za nejzávažnější celkové faktory považujeme hy­perglykémii, hypertenzi, hypercholesterolémii a diabetickou nefropatii. V textu jsou zmíněny i další vlivy včetně tě­­hotenství, porodu a early worsening syndrom (EW).

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ballegooi van E., Hooymans, J.M.M., Timmerman Z., et al.: Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care, 1984, 7/3, s. 236-242.
    2. Barnes, A.J., Kohner, E. M., Johnston, D. G., Alberti, K.G. M.: Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone. Lancet,1985, 1/8444, s. 1465-1468. Go to original source... Go to PubMed...
    3. Browning,D.J., Flynn, H.W., Blankenship, G.W.: Asymmetric retinopathy in patients with diabetes mellitus. Am. J. Ophthalmology. 1988, 105, s: 584-589. Go to original source... Go to PubMed...
    4. Boz,M., Scheen, A.J., Gerard, P. L., et al.: Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabetes Metab., 1995, 21, s.353-359.
    5. Chantelau, E.,: Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br.J.Ophthalmol., 1996, 82, s. 725-730. Go to original source... Go to PubMed...
    6. Colwell, J.A., Halushka, P.J., Sarji, A., et al.: Altered platelet function in diabetes mellitus. Diabetes,1976, 25 (suppl 2), s. 826-828. Go to PubMed...
    7. Dahl - Jorgensen, U., Brinchman - Hansen, O., Hansssen, K. F., et al.: Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus.: The Oslo Study. Br. Med. J., 1985, 290/6471, s. 811-815. Go to original source... Go to PubMed...
    8. Haffner, S.M., Klein, B.E. K., Klein, R., Moss S.E.: Sex hormones and the incidence of severe retinopathy in male subjects with type I. diabetes. Ophtalmology,1993, 100/12, s. 1782-1786. Go to original source... Go to PubMed...
    9. Olsen, T., Ehlers, N., Nielsen, C.B., Beck-Nielsen, H.:Diabetes retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII). Acta ophtalmol.1985, 63/3, s. 315-319. Go to original source... Go to PubMed...
    10. Rosenlund,E.F., Haakienes,K., Hansen, O. B., et al.:Transient proliferative diabetic retinopathy during intensified insulin treatment. Am.J. Ophtalmology, 1988, 105, s.618-625. Go to original source... Go to PubMed...
    11. Rosseti, L., Chaudhuri, J., Dickersin, K.: Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. Ophtalmology. 1988, 105, s. 397-405. Go to original source... Go to PubMed...
    12. Sharp, P.,S.,: The role of growth factor in the dewelopment of diabetic retinopathy. Metabolism,1995, 44 (10 suppl 4) s. 72-75. Go to original source... Go to PubMed...
    13. Scherrer, U., Randin, D., Vollenweider, P., Nicod, P.,: Nitric oxid release accounts for insulin's vascular effects in humans. J. Clin. Invest., 1994, 94, s. 2511-2515. Go to original source... Go to PubMed...
    14. White J.R., Campbell R.,K., Monsanto, H.A., Parent, M.: Magnesium and diabetes. Ann. Pharmacoterap., 1993, 27/6., s. 775-780. Go to original source... Go to PubMed...
    15. Yoshinari, M., Yamamoto, M. et al.: Prospective Study of asymmetric retinopathy as a predictor of brain infarction in diabetes mellitus. Diabets care, 1996, 16/10, s. 1405-1406. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.